These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32869391)

  • 41. How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis?
    Preshaw PM; Taylor JJ
    J Clin Periodontol; 2011 Mar; 38 Suppl 11():60-84. PubMed ID: 21323705
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interleukin-22-Induced Antimicrobial Phospholipase A2 Group IIA Mediates Protective Innate Immunity of Nonhematopoietic Cells against Listeria monocytogenes.
    Okita Y; Shiono T; Yahagi A; Hamada S; Umemura M; Matsuzaki G
    Infect Immun; 2016 Feb; 84(2):573-9. PubMed ID: 26644377
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium.
    Satoh-Takayama N; Dumoutier L; Lesjean-Pottier S; Ribeiro VS; Mandelboim O; Renauld JC; Vosshenrich CA; Di Santo JP
    J Immunol; 2009 Nov; 183(10):6579-87. PubMed ID: 19846871
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulation of the human cytokine response by interferon lambda-1 (IFN-lambda1/IL-29).
    Jordan WJ; Eskdale J; Boniotto M; Rodia M; Kellner D; Gallagher G
    Genes Immun; 2007 Jan; 8(1):13-20. PubMed ID: 17082759
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens.
    Zheng Y; Valdez PA; Danilenko DM; Hu Y; Sa SM; Gong Q; Abbas AR; Modrusan Z; Ghilardi N; de Sauvage FJ; Ouyang W
    Nat Med; 2008 Mar; 14(3):282-9. PubMed ID: 18264109
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases.
    Calcagni E; Elenkov I
    Ann N Y Acad Sci; 2006 Jun; 1069():62-76. PubMed ID: 16855135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease.
    Ouyang W
    Cytokine Growth Factor Rev; 2010 Dec; 21(6):435-41. PubMed ID: 21106435
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of Interleukin-32 in autoimmunity.
    de Albuquerque R; Komsi E; Starskaia I; Ullah U; Lahesmaa R
    Scand J Immunol; 2021 Feb; 93(2):e13012. PubMed ID: 33336406
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin-26: An Emerging Player in Host Defense and Inflammation.
    Tengvall S; Che KF; Lindén A
    J Innate Immun; 2016; 8(1):15-22. PubMed ID: 26202572
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Caspase-1-processed IL-1 family cytokines play a vital role in driving innate IL-17.
    Dungan LS; Mills KH
    Cytokine; 2011 Oct; 56(1):126-32. PubMed ID: 21824786
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Engagement of the Aryl Hydrocarbon Receptor in Mycobacterium tuberculosis-Infected Macrophages Has Pleiotropic Effects on Innate Immune Signaling.
    Memari B; Bouttier M; Dimitrov V; Ouellette M; Behr MA; Fritz JH; White JH
    J Immunol; 2015 Nov; 195(9):4479-91. PubMed ID: 26416282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Recent progress in the pathophysiological role of interleukin-19].
    Fujimoto Y; Azuma YT
    Nihon Yakurigaku Zasshi; 2019; 154(2):66-71. PubMed ID: 31406045
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cutting Edge: IL-17B Uses IL-17RA and IL-17RB to Induce Type 2 Inflammation from Human Lymphocytes.
    Ramirez-Carrozzi V; Ota N; Sambandam A; Wong K; Hackney J; Martinez-Martin N; Ouyang W; Pappu R
    J Immunol; 2019 Apr; 202(7):1935-1941. PubMed ID: 30770417
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential macrophage expression of IL-12 and IL-23 upon innate immune activation defines rat autoimmune susceptibility.
    Andersson A; Kokkola R; Wefer J; Erlandsson-Harris H; Harris RA
    J Leukoc Biol; 2004 Dec; 76(6):1118-24. PubMed ID: 15371491
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Innate IL-17 and IL-22 responses to enteric bacterial pathogens.
    Rubino SJ; Geddes K; Girardin SE
    Trends Immunol; 2012 Mar; 33(3):112-8. PubMed ID: 22342740
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interleukin-32: An endogenous danger signal or master regulator of intracellular pathogen infections-Focus on leishmaniases.
    Dos Santos JC; Damen MSMA; Joosten LAB; Ribeiro-Dias F
    Semin Immunol; 2018 Aug; 38():15-23. PubMed ID: 29551246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IL-33-mediated innate response and adaptive immune cells contribute to maximum responses of protease allergen-induced allergic airway inflammation.
    Kamijo S; Takeda H; Tokura T; Suzuki M; Inui K; Hara M; Matsuda H; Matsuda A; Oboki K; Ohno T; Saito H; Nakae S; Sudo K; Suto H; Ichikawa S; Ogawa H; Okumura K; Takai T
    J Immunol; 2013 May; 190(9):4489-99. PubMed ID: 23547117
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytokines and the host defense against Listeria monocytogenes and Salmonella typhimurium.
    Langermans IA; van Furth R
    Biotherapy; 1994; 7(3-4):169-78. PubMed ID: 7865348
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity.
    Colonna M
    Immunity; 2009 Jul; 31(1):15-23. PubMed ID: 19604490
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases.
    Egwuagu CE; Yu CR; Sun L; Wang R
    Cytokine Growth Factor Rev; 2015 Oct; 26(5):587-93. PubMed ID: 26279360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.